The first patents of recombinant-DNA-derived biopharmaceuticals will expire in the near future, which should allow the marketing of 'generics'. With classical drugs, generics can be marketed on the ...

A 29-year-old female healthcare worker presented for a blood test to confirm a response to her initial COVID-19 vaccine. A day after receiving the vaccine she fell, which resulted in wounds that ...

Assessing the immunogenicity, the ability of a foreign substance to elicit an immune response, of any drug or therapeutic is essential to assessing efficacy and toxicity at the early stages of drug ...

Early Removal of T-Cell Epitopes Reduces Risk of Adverse Immune Responses in Patients The development of therapeutic proteins such as humanized antibodies and fully human antibodies has in many ...

A discussion of the basic principles of immunity and the nature of antibodies. a patient's characteristics and/or genetic background. The 'wanted' immunogenicity requires computational analysis of ...

As biologics and biosimilars continue to reshape oncology, ensuring their safety and efficacy remains a top priority. In this expert-driven report, Cerba Research examines the latest advancements in ...

The 2nd Gene Therapy Immunogenicity Summit is the industry's definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate. In the context of ...